원문 보기
Okay, welcome to Wall Street X. My name is Hugh and I have a master's degree in finance, and we're going to look at how Katie Wood makes big bets on these eight stocks. As a reminder, most active funds do not outperform the S&P 500 over the long term, and you should always do your own research, but to get you started, we have Cerebra Systems, CBRS.
Katie Wood added 89,000 shares of this company to the ARC Innovation Fund today, which is June 2025, bringing her total portfolio holdings to just over 23% of this ARC Innovation ETF. Cerebers has fallen 30% in the last month and we expect it to fall another 45% over the next year with a strong sell rating.
However, on the contrary, on average, analysts rate it as a strong buy with an annual growth of plus 77%. So, there are two different stories for CBRS. But then we're talking about Robin Hood Markets NASDAQ. She added about 25,000 shares to the ARC Innovation Fund, increasing the total portfolio weight to 5%.
Robin Hood shares have recently recovered after falling 50% from their recent highs, and currently have a decent PEG ratio of around 1.1. We rated Robin Hood as a strong buy with a one-year outlook of 26%, and analysts on average rated it a buy with 32% upside potential. Palanteer Technologies was also added .
She added 22,000 shares of Palanteer PLTR, which now represents 4% of her portfolio. Stocks that have fallen 37% since the beginning of the year . They had a bad year. We rated Palanteer as a Buy with a one-year price forecast of 8%, and analysts also rated it as a Buy, but with a much higher one-year forecast of -36%.
Recursion Pharmaceuticals RXRX Katie added 565,000 shares of Recursion, which now represents 3% of her portfolio. Recursion currently has a staggering price- to-sales ratio of 26 shares. Huge price to sales, considering the price to profit ratio. Maybe not today, but today it is extremely high for the sales price, but the projected revenue growth is 31% year-over-year .
This is higher than the sales price. So, that's a really good PSG coefficient below one. But, uh , our rating for RXRX right now is a strong buy with 53% annual growth. And analysts rated it as a buy with a projected annual return of 132%. Very high risk, high reward for this one, but we rated it pretty well.
Coinbase Global Inc Coin on NASDAQ CO N shares. Katie Wood purchased an additional 6,500 shares of Coinbase. That's about a million dollars, which continues to take up about 1% of her ARC Innovation Fund. Coinbase is very highly valued with a P/E ratio of 59, but makes up for it with projected annual EPS growth of 124%, giving them an incredible PEG ratio of 0.5.
We like the PEG ratio here. Anything below one is really good, 0.5 is just fantastic. We rated Coin as a strong buy with 97% year-over-year growth, while analysts rated it as a buy with 70% year-over-year growth . This is definitely one of the strongest stocks on the list. She added that shares of X Energy Inc.
NASDAQ XE aggregates about 26,000 stocks. This will result in the current portfolio awaiting sales being only 0.7% of its portfolio. XE's pre-sales share price is 44, but it has projected growth, er, revenue growth that matches the forecast at 43% over the next 12 months. Our estimate for XE is to sell with a 4% discount.
So, not bad considering, but analysts are much more optimistic with a "buy" forecast and an average rating of 59%. So we're definitely a little pessimistic about that. Circle internet group or CRCL shares on the New York Stock Exchange. Katie Wood added 6,800 shares of this company, giving the portfolio a weight of 0.7, the same as X Energy.
Currently, it's a pretty good value at five times sales price and projected revenue growth of 21%. Thus, we rated it a "strong buy" with a price forecast of 24% for one year, and analysts consider it a "buy" with a rating of 44% for that time. And the last stock on this list is the “bullish” NYSE BLS stock.
She bought and added 6,700 shares to this portfolio . It now accounts for only 2% of this portfolio. The bullish stock is now down about 67% over the past year, but has an estimated 18% revenue growth rate over the next 12 months. To put that into perspective, we rated this stock as a "buy" with a 9% upside over the next year, and analysts on average rated it as a " buy" with an average annual growth rate of plus 77%.
Huge growth forecast. These are eight stocks that Katie Wood recently added to the Arc Innovation Fund. Thank you very much for watching. Please like if you enjoyed it and I'll take a look.
Comments 0